ARTICLE | Clinical News
Ii-Key/HER2/neu cancer vaccine: Completed Phase II enrollment
January 27, 2014 8:00 AM UTC
Generex completed enrollment of >300 patients with node-positive or high-risk, node-negative breast cancer in a single-blind, international Phase II trial evaluating 6 monthly intradermal inoculations...